InvestorsHub Logo

Ernesto

04/29/16 4:21 PM

#146236 RE: DaubersUP #146227

The article Sox posted misquoted the article they cited for Ovarian market size. They link to the following:

https://www.alliedmarketresearch.com/oncology-cancer-drugs-market

Which states:

"The global oncology drugs market is expected to reach at $111.9 billion by 2020."



Ovarian is a tiny chunk of that, hence the Orphan Drug Designation. That being said, that's a big pie overall and Kevetrin will hopefully be a big player.